Vistagen Therapeutics Inc (VTGN)
4.37
-0.10
(-2.24%)
USD |
NASDAQ |
May 10, 16:00
4.37
0.00 (0.00%)
After-Hours: 20:00
Vistagen Therapeutics Free Cash Flow (Quarterly): -4.568M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.568M |
| September 30, 2023 | -6.190M |
| June 30, 2023 | -7.891M |
| March 31, 2023 | -7.473M |
| December 31, 2022 | -9.946M |
| September 30, 2022 | -16.37M |
| June 30, 2022 | -16.14M |
| March 31, 2022 | -15.59M |
| December 31, 2021 | -12.05M |
| September 30, 2021 | -11.50M |
| June 30, 2021 | -6.323M |
| March 31, 2021 | -5.307M |
| December 31, 2020 | -5.140M |
| September 30, 2020 | 0.9049M |
| June 30, 2020 | -2.807M |
| March 31, 2020 | -2.579M |
| December 31, 2019 | -4.280M |
| September 30, 2019 | -4.137M |
| June 30, 2019 | -4.761M |
| March 31, 2019 | -3.561M |
| December 31, 2018 | -3.907M |
| September 30, 2018 | -4.062M |
| June 30, 2018 | -3.171M |
| March 31, 2018 | -2.604M |
| December 31, 2017 | -2.445M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.877M |
| June 30, 2017 | -2.134M |
| March 31, 2017 | -1.523M |
| December 31, 2016 | -2.097M |
| September 30, 2016 | -2.208M |
| June 30, 2016 | -1.673M |
| March 31, 2016 | -1.331M |
| December 31, 2015 | -1.174M |
| September 30, 2015 | -1.506M |
| June 30, 2015 | -0.8233M |
| March 31, 2015 | -0.8945M |
| December 31, 2014 | -0.341M |
| September 30, 2014 | -0.5216M |
| June 30, 2014 | -1.012M |
| March 31, 2014 | -0.4671M |
| December 31, 2013 | -0.3184M |
| September 30, 2013 | -0.6087M |
| June 30, 2013 | -0.7414M |
| March 31, 2013 | -0.9743M |
| December 31, 2012 | -1.094M |
| September 30, 2012 | -1.234M |
| June 30, 2012 | -0.2962M |
| March 31, 2012 | -0.7376M |
| December 31, 2011 | -1.064M |
| September 30, 2011 | -0.71M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-16.37M
Minimum
Sep 2022
0.9049M
Maximum
Sep 2020
-7.481M
Average
-6.190M
Median
Sep 2023
Free Cash Flow (Quarterly) Benchmarks
| Ardelyx Inc | -35.87M |
| Axsome Therapeutics Inc | -53.56M |
| Vir Biotechnology Inc | -109.46M |
| Immuneering Corp | -11.95M |
| NovaBay Pharmaceuticals Inc | -0.316M |